Humoral Response to SARS-CoV-2 mRNA Vaccine in Heart Transplant Recipients up to 4 Months After the Third Vaccine Injection

PURPOSE: Recent studies reported poor to moderate humoral response after 2 vaccine doses in heart transplant recipients (HTR). Currently, French authorities recommend 2 and 3 vaccine injections for transplant recipients with and without prior SARS-CoV-2 infection, respectively. This study aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferré, V.M., Brouk, Z., Flament, H., Kerneis, C., Charpentier, C., Verdonk, C., Vicaut, E., De Chaisemartin, L., Descamps, D., Houhou-Fidouh, N., Dorent, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(660)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988605/
http://dx.doi.org/10.1016/j.healun.2022.01.681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988605/
http://dx.doi.org/10.1016/j.healun.2022.01.681

Ejemplares similares